Quinazolinone and quinazoline derivatives: recent structures with potent antimicrobial and cytotoxic activities
Abstract
The heterocyclic compounds have a great importance in medicinal chemistry. One of the most important heterocycles in medicinal chemistry are quinazolines possessing wide spectrum of biological properties like antibacterial, antifungal, anticonvulsant, anti-inflammatory, anti-HIV, anticancer and analgesic activities. This skeleton is an important pharmacophore considered as a privileged structure. This review highlights the recent advances in the synthesis of quinazolines and quinazolinone derivatives with potent antimicrobial and cytotoxic activities.
Full Text:
PDFReferences
Samira I, Patel S, Hasmin M, Patel S. Biological profile of quinazoline. Int J Pharm Chem Sci. 2012;1:1863-1872.
Singh VK, Singh SK, Gangwar L. Synthesis and antimicrobial activity of novel fused 4-(3H) quinazolinone derivatives. Int J Sci Res. 2013;2: 425-428.
Ghorab MM, Ismail Z, Radwan AA, Abdalla M. Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety. Acta Pharm. 2013;63:1–18.
Vijayakumar K, Ahamed AJ, Thiruneelakandan G. Synthesis, antimicrobial, and anti-HIV1 activity of quinazoline-4(3H)-one derivatives. J Applied Chem. 2013;2013:ID 387191.
Deep A, Narasimhan B, Ramasamy K, Mani V, Mishra RK, Majeed AB. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of thiazolidin-4-ones clubbed with quinazolinone. Curr Top Med Chem. 2013;13:2034-2046.
Al-Amiery AA, Kadhum AAH, Shamel M, Satar M, Khalid Y, Mohamad AB. Antioxidant and antimicrobial activities of novel quinazolinones. Med Chem Res. 2014;23:236–242.
Laddha SS, Wadod Kar SG, Meghal SK. Studies on some biologically active substituted 4(3H)-quinazolinones. Part 1. Synthesis, characterization and anti-inflammatory, antimicrobial activity of 6,8-disubstituted 2-phenyl-3-[substituted- benzothiazol-2-yl]-4(3H)-quinazolinone. Arkivoc. 2006;11:1-20.
Giri RS, Thaker HM, Giordano T, Williams J, Rogers D, Sudersanam V, et al. Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazolin-4-one derivat-ives as inhibitors of NF-ĸB and AP-1 mediated transcription activation and as potential anti-inflammatory agents. Eur J Med Chem. 2009;44:2184-2189.
Jiang S, Zeng Q, Gettayacamin M, Tungtaeng A, Wannaying S, Lim A, et al. Antimalaria activities and therapeutic properties of febrifugine analogs. Antimicrob Agents Chemoter. 2005,49:1169-1176.
Deetz MJ, Malerich JP, Beatty AM, Smith BD. One-step synthesis of 4(3H) quinazolinones. Tetrahedron Lett. 2001;42:1851-1854.
Krishnan SK, Ganguly S, Veeramy R, Jan B. Synthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones. Eur Rev Med Pharmacol Sci. 2011;15:673-681.
Khosropour AR, Mohammadpoor-Baltork I, Ghorbankhani H. Bi (TFA) 3-[nbp] Fecl4: A new, efficient and reusable promoter system for the synthesis of 4(3H)-quinazolinone derivatives. Tetrahedron Lett. 2006;47:3561-3564.
Al-Rashood ST, Aboldahab IA, Nagi MN, Abouzeid LA, Abdel-Aziz AAM, Abdel-hamide SG, et al. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg Med Chem. 2006;14:8608-8621.
Liu S, Liu F, Yu X, Ding G, Xu P, Cao J. et al. The 3D-QSAR analysis of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains on thymidylate synthase. Bioorg Med Chem. 2006;14:1425-1430.
Hattori K, Kido Y, Yamamoto H, Ishida J, Iwashita A, Mihara K. Rational design of conformationally restricted quinazolinone inhibitors of poly (ADP-ribose) polymerase. Bioorg Med Chem Lett. 2007;17:5577-5581.
Guiles J, Sun X, Critchley IA, Ochsner U, Tregay M, Stone K, et al. Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III. Bioorg Med Chem Lett. 2009;19:800-802.
Orvieto F, Branca D, Giomini C, Jones P, Koch U, Ontoria JM, et al. Identification of substituted pyrazolo [1,5-a] quinazolin-5 (4H)-one as potent poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors. Bioorg Med Chem Lett. 2009;19: 4196-4200.
Khalil AA, Abdel hamide SG, Al-Obaid AM, El-subbagh H. Substituted quinazolinones, Part2. Synthesis and in vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazolin analogs. Arch Pharm Pharm Med Chem. 2003;336:95-103.
Nagar AA, Rathi LG, Chugh N, Pise VJ, Bendale A. Microwave assisted one pot synthesis of 2, 3-di-substituted quinazolin-4- (3H)-ones and their potential biological activity. Der Pharm Chem. 2010;2:37-43.
Selvam TP, Kumar PV. Quinazoline Marketed drugs – A Review. Res Pharm. 2011;1:1-21.
Abida, Parvez N, Rana A, Imran M. An updated review: newer quinazoline derivatives under clinical trial. Int J Pharm Biol Arch. 2011;2:1651-1657.
Mohamed MA, Ghanem HM, Abd El-Ghaffar NF, Mohamed SS. Biological evaluation and molecular docking of substituted quinazolinones as antimicrobial agents. AustJ Basic Appl Sci. 2013;7:263-274.
Zayed MF, Hassan MH. Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm J. 2014;22:157-162.
El-Badry YA, Anter NA, El-Sheshtawy HS. Synthesis and evaluation of new polysubstituted quinazoline derivatives as potential antimicrobial agents. Der Pharma Chemica, 2012;4:1361-1370.
Dave RS, Odedara RJ , Kalaria RI, Upadhyay JJ. Synthesis, characterization and antimicrobial activity of new quinazolin- 4(3H)-one schiff base derivatives. J Chem Pharm Res. 2012;4:4864-4869.
Devi KA, Sriram MS. Synthesis and antimicrobial activity of some quinazolinones derivatives. Int J Drug. 2012;4: 324-327.
Raval JP, Desai KG, Desai KR. Microwave synthesis, characterization and antimicrobial study of new pyrazolyl-oxopropyl-quinazolin-4(3H)-one derivatives. J Saudi Chem Soc. 2012;16:387-393.
Sojitra NA, Dixit RB, Patel RK, Patel JP, Dixit BC. Classical and microwave assisted synthesis of new 4-(3,5-dimethyl-1-phenyl-1H-pyrazol-4-ylazo)-N-(2 -substituted-4-oxo-4H-quinazolin-3-yl) benzene-sulfonamide derivatives and their antimicrobial activities. J Saudi Chem Soci. 2012:In press.
Unnissa SH, Reddy GK. Synthesis and antimicrobial screening of 3H-Quinazolin-4-ones containing 3-methyl pyrazolinone moiety. Current Pharma Res. 2012;3:690-696.
Kumar A, Sharma P, Kumari P, Lal Kalal B. Exploration of antimicrobial and antioxidant potential of newly synthesized 2,3-disubstitut- ed quinazoline-4(3H)-ones. Bioorg Med Chem. Lett.
;21:4353–4357.
Desai NC, Dodiya A, Shihory N. Synthesis and antimicrobial activity of novel quinazolinone–thiazolidine–quinoline compounds. J Saudi Chem Soc. 2013;17:259-267.
Patel NB, Patel JC. Synthesis and antimicrobial activity of Schiff bases and 2-azetidinones derived from quinazolin-4(3H)-one. Arabian J Chem. 2011;4:403-411.
Desai NC, Dodiya A, Bhatt N, Kumar M. Dimeric 2-(2-chlorophenyl)-quinazolin-4-ones as potential antimicrobial agents. Med Chem Res. 2012;21:1127–1135.
Hassanzadeh F, Rahmani Khajouei M, Hakimelahi GH, Jafari E, Khodarahmi GA. Synthesis of some new 2,3-disubstituted-4(3H)quinazolinone derivat-ives. Res Pharm Sci. 2012;7:23-30.
Khodarahmi GA, Rahmani Khajouei M, Hakimelahi GH, Abedi D, Jafari E, Hassanzadeh F. Antibacterial, antifungal and cytotoxic evaluation of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives. Res Pharm Sci. 2012;7:151-158.
Rajasekaran A, Rajamanickam V, Darlinquine S. Synthesis of some new thioxoquinazolinone derivatives and a study on their anticonvulsant and antimicrobial activities. Eur Rev Med Pharmacol Sci. 2013;17:95-104.
Al-Omary FAM, Hassan GS, El-Messery SM, Nagi MN, Habib ESE, El-Subbagh HI. Nonclassical antifolates, part 3: Synthesis, biological evaluation and molecular modeling study of some new 2-heteroarylthio-quinazolin-4-ones. Eur J Med Chem. 2013;63:33-45.
Ryu CK, Kim YH, Im HA, Kim JY, Yoon JH, Kim A. Synthesis and antifungal activity of 6,7-bis(arylthio)-quinazoline-5,8-diones and furo[2,3-f]quinazolin-5-ols. Bioorg Med Chem Lett. 2012;22:500-503.
Shi LP, Jiang KM, Jiang JJ, Jina Y, Tao YH, Li K, et al. Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives. Bioorg Med Chem Lett. 2013;23: 5958-5963.
Mujalda V, Tiwari S, Sharma V, Saxena P, Shrivastava M. Synthesis and antimicrobial evaluation of some new quinazoline based thiosemicarbazones. Int J Chem Tech Res. 2012;4:1033-1037.
Saravanan G, y Alagarsamy V, Prakash CR. Synthesis, characterization and in vitro antimicrobial activity of some 1-(substitutedbenzylidene)-4-(4-(2-(methyl/phenyl)-4-oxoquinazolin-3(4H)-yl)phenyl) semicarbazide derivatives. J Saudi Chem Soci. 2015;19:3-11.
Suresha GP, Suhas R, Kapfo W, Gowda DC. Urea/thiourea derivatives of quinazolinoneelysine conjugates: Synthesis and structure activity relationships of a new series of antimicrobials. Eur Med Chem. 2011;46:2530-2540.
Kuarm BS, Reddy YT, Madhav JV, Crooks PA, Rajitha B. 3-[Benzimidazo- and 3-[benzothia-diazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agents. Bioorg Med Chem Lett. 2011;21:524–527.
Jafari E, Khodarahmi GA, Hakimelahi GA, Tsai FY, Hassanzadeh F. Synthesis of some new tricyclic 4(3H)-quinazolinone derivatives. Res Pharm Sci. 2011;6:93-100.
Hassanzadeh F, Jafari E, Hakimelahi GH, Rahmani Khajouei M, Jalali M, Khodarahmi GA. Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives. Res Pharm Sci. 2012;7:87-94.
Khodarahmi GA, Jafari E, Hakimelahi GH, Abedi D, Rahmani Khajouei M, Hassanzadeh F. Synthesis of some new quinazolinone derivatives and evaluation of their antimicrobial activities. Iran J Pharm Res. 2012;11:789-797.
Alafeefy AM, El-Azab AS, Mohamed MA, Bakhat MA, Abdel-Hamid SG. Synthesis of some new substituted iodoquinazoline derivatives and their antimicrobial screening. J Saudi Chem Soc. 2011;15:319–325.
Hu S, Xie G, Zhang DX, Davis C, Long W, Hu Y, et al. Synthesis and biological evaluation of crown ether fused quinazoline analogues as potent EGFR inhibitors. Bioorg Med Chem Lett. 2012;22: 6301–6305.
Kh. Atia AJ, Al-Mufrgeiy SS. Synthesis and antibacterial activities of new 3-amino-2-methyl-quinazolin-4 (3h)-one derivatives. American J Chem. 2012;2:150-156.
Kinoshita T, Nakanishi I, Warizaya M, Iwashita A, Kido Y, Hattori K, et al. Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase. FEBS Letters. 2004;556:43-46.
Jin Y, Zhou ZY, Tian W, Yu Q, Long YQ. 4'-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3', 4', 5'-substituted) anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents. Bioorg Med Chem Lett. 2006;16:5864-5869.
Wissner A, Fraser HL, Ingalls CL, Dushin RG, Floyd MB, Cheung K, et al. Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2. Bioorg Medi Che. 2007;15:3635–3648.
Abouzid K, Shouman S. Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. Bioorg Med Chem. 2008;16: 7543–7551.
Fernandes C, Oliveira C, Gano L, Bourkoula A, Pirmettis I, Santos I. Radioiodination of new EGFR inhibitors as potential SPECT agents for molecular imaging of breast cancer. Bioorg Med Chem. 2007;15:3974–3980.
Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, Abdel-Aziz AM, El-Azab AS, Al-Khamees HA, et al. Substituted quinazolines, part 3. Synthesis, in vitro antitumoractivity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs. Eur J Med Chem. 2009;44:2379–2391.
Al-Omary FAM, Abou-zeid LA, Nagi MN, Habib ESE, Abdel-Aziz AAM, El-Azab AS, et al. Non-classical antifolates. Part 2: Synthesis, biological evaluation, and molecular modeling study of some new 2,6-substituted-quinazolin-4-ones. Bioorg Med Chem. 2010;18:2849–2863.
Raffa D, Edler MC, Daidone G, Maggio B, Merickech M, Plescia S, et al. Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. Eur J Med Chem. 2004;39:299-304.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.